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We examined the role of CD4, CXCR4, and CCR5 in HIV envelope-mediated apoptosis by measuring the response of
activated PBMCs to recombinant envelope proteins derived from CXCR4- and CCR5-utilizing viruses. Apoptosis of T cells was
assessed by annexin-V staining and TdT-mediated dUTP-biotin nick-end labeling. Treatment of CCR5D32 homozygote PBMCs
with a CCR5-specific envelope induced apoptosis in T cells, demonstrating that envelope–CD4 interactions are sufficient to
induce apoptosis. However, a CXCR4-specific envelope induced higher levels of apoptosis than a CCR5-specific envelope,
suggesting that envelope-mediated apoptosis can be enhanced by envelope–CXCR4 interactions. We conclude that envelope
can induce apoptosis in T cells independently of the coreceptor specificity of a given envelope, or the expression profile of
CXCR4 or CCR5 on a target cell. However, envelope–coreceptor interactions, and in particular, envelope–CXCR4 interactions,
can contribute to this process. © 2002 Elsevier Science
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The depletion of CD41 T lymphocytes is a central
pathogenic feature of HIV-1 infection and is largely re-
sponsible for the profound immunodeficiency that is
characteristic of late stages of HIV disease (Fauci, 1996;
Mossman et al., 1996). Although the mechanisms leading
to CD41 T cell decline remain to be elucidated, it is
generally agreed that cytolysis resulting from direct in-
fection (Ho et al., 1995) and enhanced rates of apoptosis
(Badley et al., 1997; Groux et al., 1992; Monte et al., 1992)
contribute to this process. Paradoxically, although CD41
T lymphocytes represent the principal target of infection,
relatively few CD41 T lymphocytes are infected (Biberfeld
et al., 1986), even in the presence of clinically high viral
loads. Thus, additional mechanisms associated with vi-
ral replication but independent of direct infection are
also believed to contribute to CD41 T cell killing. Several
virally encoded proteins, including Tat (McCloskey et al.,
1997) and Vpr (Stewart et al., 2000), have been implicated
in HIV-mediated apoptosis. In addition, numerous stud-
ies have demonstrated that the viral envelope protein
enhances the rate of apoptosis in activated CD41 T cells
(Chirmule and Pahwa, 1996; Cicala et al., 2000; Finkel et
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98al., 1995; Herbein et al., 1998; Ullrich et al., 2000). Thus,
envelope proteins, present either as soluble proteins or
on the surface of infectious and/or defective viral parti-
cles, have the potential to contribute to CD41 T cell
depletion in vivo. This potential is underscored by the
presence of high concentrations of envelope protein in
lymphoid tissues (Sunila et al., 1997).
Envelope-mediated apoptosis of T cells is a conse-
quence of envelope-mediated signal transduction. In this
regard a number of laboratories have demonstrated that
envelope proteins transduce signals through the CD4
receptor as well as through the fusion coreceptors, CCR5
and CXCR4 (Cicala et al., 1999; Davis et al., 1997; Hivroz
et al., 1993; Popik et al., 1998; Tamma et al., 1997).
Envelope-mediated signal transduction through CD4 re-
sults in the phosphorylation of p56-Lck (Hivroz et al.,
1993), while envelope signals delivered through CCR5
and CXCR4 result in responses that mimic chemokine-
mediated signal transduction (Bacon et al., 1996; Cicala
et al., 1999; Davis et al., 1997; Ganju et al., 1998). Most
notably, envelope engagement of CCR5 results in che-
motaxis (Weissman et al., 1997), calcium mobilization
(Arthos et al., 2000), and the phosphorylation of several
substrates including PYK-2 (Davis et al., 1997), FAK
(Cicala et al., 1999), ZAP-70 (Tamma et al., 1997), and
CCR5 (Cicala et al., 1999).
Although envelope can signal through CD4, CCR5, and
CXCR4, it is unclear which of these signals participates
in envelope-mediated apoptosis of primary T cells. Prior
to the identification of CCR5 and CXCR4 as HIV corecep-
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linking the CD4 receptor with monoclonal antibodies
increased rates of apoptosis in activated CD41 T cells
(Finkel et al., 1995). Similarly, Berndt and colleagues
demonstrated that monoclonal antibody (mAb)-mediated
CD4 crosslinking induces apoptosis, but only by CD4
mAbs that recognize the gp120 binding site on CD4
(Berndt et al., 1998). These observations suggest that
CD4 engagement by gp120 alone could account for en-
velope-mediated apoptosis. A number of studies have
demonstrated that envelope–CXCR4 interactions can in-
duce apoptosis (Berndt et al., 1998; Biard-Piechaczyk et
al., 2000; Colamussi et al., 2000; Hesselgesser et al.,
1998; Kaul and Lipton, 1999; Ohagen et al., 1999; Ullrich
et al., 2000; Zheng et al., 1999). However, the role of
CXCR4 signaling in apoptosis is unclear. Some research-
ers have found that SDF-1a induces apoptosis (Cola-
mussi et al., 2000), while others have found that it pro-
tects cells from apoptosis (Blanco et al., 1999). Unlike
CD4 and CXCR4, envelope–CCR5 interactions have not
yet been implicated in envelope-mediated apoptosis.
The potential role of CXCR4, but not CCR5, in apoptosis
is noteworthy in light of the differential effects of CXCR4 (X4)
vs CCR5 (R5) viruses in vivo. R5 viruses are preferentially
transmitted and predominate during the early stages of
disease (van’t Wout et al., 1994). However, in some individ-
uals the viral quasispecies evolves to a predominantly X4-
utilizing phenotype. These individuals typically experience
a more rapid decline in CD41 T cells and an increased rate
of disease progression (Cheng-Mayer et al., 1988; Ters-
mette et al., 1989a,b). Thus, the acquisition of CXCR4 spec-
ificity is correlated with a more cytopathic virus and implies
that envelope–CXCR4 interactions might be intrinsically
more cytopathic to target cells than envelope–CCR5 inter-
actions. However, in a series of reports, Grivel and col-
leagues, utilizing explanted lymphoid tissue, have convinc-
ingly demonstrated that, in the context of active replication,
R5 and X4 viruses are similarly cytopathic, but that X4
viruses deplete CD41 T cells to a greater extent because
the range of target cells that express CXCR4 is much
greater (Grivel et al., 2000a,b; Grivel and Margolis, 1999).
Thus, it remains unclear whether envelope–CXCR4 en-
gagement induces apoptosis to a greater degree than en-
velope–CCR5 engagement.
In this study we have compared the capacity of pri-
mary X4 vs R5 specific envelopes to induce apoptosis in
activated T cells. In addition, we have dissected the role
of envelope-mediated CD4 signaling vs chemokine-re-
ceptor signaling in envelope-mediated apoptosis.
RESULTS
Induction of apoptosis in peripheral blood T cells;
comparison of a primary R5 vs X4 envelopeTo quantitatively compare the capacity of R5 and X4
envelopes to induce apoptosis in activated peripheralblood mononuclear cells (PBMCs), freshly isolated
PBMCs were activated with OKT3/IL2 for 3 days prior to
treatment with envelope. We employed two independent
assays. Increased exposure of phosphatidyl-serine on
the outer surface of the cell membrane is one of the
earliest events associated with the commitment of a cell
to apoptosis and can be measured flow cytometrically
with fluorescein-conjugated annexin-V (Bossy-Wetzel
and Green, 2000). Degradation of chromosomal DNA
occurs at the end of programmed cell death and can be
measured flow cytometrically via TdT-mediated dUTP-
FITC nick-end labeling (TUNEL) (Carbonari et al., 1995).
We compared two recombinant gp120s derived from pri-
mary viral isolates. 92MW959 gp120 was derived from an
isolate that uses CCR5 exclusively, while 92UG21-9 was
derived from an isolate that utilizes CXCR4 exclusively
(Moore et al., 1997).
We first compared the capacity of the X4 and R5
envelopes to induce apoptosis using the annexin-V as-
say. Five hours after envelope treatment, PBMC cultures
were analyzed for annexin-V and propidium iodide (PI)
staining. Cells staining positive for annexin-V and nega-
tive for PI were considered in the early stages of pro-
grammed cell death. The X4-specific envelope increased
annexin-V reactivity fourfold (Fig. 1C). Utilizing the same
donor PBMCs, the increase in apoptosis in response to
the R5 envelope was twofold (Fig. 1D). In addition, fresh
PBMCs were treated with the same recombinant enve-
lopes and analyzed by TUNEL 65 h posttreatment (Figs.
1F–1J). TUNEL reactivity increased by more than twofold
in all donors in response to the X4 envelope. The in-
crease in TUNEL positivity resided within the population
that excluded the CD8-bright lymphocyte population. Of
note the CD8-bright cells failed to apoptose in the pres-
ence of the anti-FAS mAb, CH11, even though this pop-
ulation expresses CD95 (data not shown), indicating that
in the culture system we employed, this population ap-
peared resistant to apoptosis. Hence, in subsequent
experiments we did not specifically address the levels of
apoptosis in CD8-bright cells. We cannot exclude the
possibility that populations other than CD41 T cells un-
dergo apoptosis in response to envelope, and the effects
of envelope on these subsets is currently under investi-
gation (J. Arthos and C. Cicala, unpublished results).
In summary, both the R5 and X4 envelopes demon-
strated the capacity to induce apoptosis in T cell lym-
phocytes. However the X4-specific envelope induced
apoptosis to a greater degree, suggesting that signaling
through CXCR4 may more effectively contribute to the
induction of apoptosis than signaling through CCR5.
R5 envelopes induce apoptosis in PBMCs derived
from a CCR5D32 homozygous individualWe next asked whether envelope–CD4 interactions in
the absence of envelope–coreceptor interactions can
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we employed freshly isolated PBMCs derived from two
individuals homozygous for a 32 base-pair (bp) deletion
in the CCR5 gene (CCR5D32 null) (Liu et al., 1996; Sam-
son et al., 1996). T cells from these individuals fail to
present CCR5 on the cell surface (Samson et al., 1996);
thus treatment with an R5 envelope should mediate ef-
fects exclusively through the CD4 receptor. Cells were
treated with either 92MW959 gp120 (R5) or a second
CCR5-specific envelope, JR-FL gp120 (O’Brien et al.,
1990). Sixty-five hours after envelopes were added, we
observed increases in the number of TUNEL positive T
cells in cultures treated with either R5-specific envelope
(Figs. 2B, 2C, 2E, and 2F). In addition, if an R5 envelope
was preincubated with a molar excess of sCD4, this
effect was abrogated, further confirming that the apopto-
sis we observed in these individuals is dependent upon
envelope–CD4 interactions. We conclude that envelope-
mediated apoptosis can occur in the absence of both
gp120-CCR5 and gp120-CXCR4 engagement.
Soluble CD4 enhances X4 gp120-mediated apoptosis
in T lymphocytes
The data presented thus far indicate that although
envelope–CD4 interactions are sufficient to induce apop-
tosis, interactions with HIV coreceptors, particularly
CXCR4, may enhance this phenomenon. We next asked
whether envelope–CXCR4 interactions in the absence of
CD4 signaling are sufficient to mediate apoptosis. For
most X4-specific envelopes, including 92Ug21-9, efficient
engagement of CXCR4 is dependent upon an initial in-
teraction with CD4 (Salzwedel et al., 2000). This engage-
ment leads to conformational changes in gp120 that
increase its apparent affinity for CXCR4 (Lapham et al.,
1996). To eliminate envelope signaling through CD4
while achieving the necessary change in conformation of
envelope, we preincubated 92Ug21-9 gp120 with a molar
excess of sCD4.
Treatment of PBMCs with these complexes was com-
pared to treatment with 92Ug21-9 gp120 alone. In the two
donors we tested, addition of gp120–sCD4 complexes
(Figs. 3C and 3G) resulted in a higher level of apoptosis
than addition of gp120 alone (Figs. 3B and 3F). As ex-
pected, the addition of sCD4 alone had no measurable
effect on apoptosis (Figs. 3D and 3H). We conclude that
FIG. 1. Comparison of apoptosis induced by an R5 and an X4 envelop
stimulated PBMCs after 5 h of treatment at 37°C. Light scatter of cells inclu
(B), as are positive controls using the anti-FAS mAb CH11 (E). Treatment w
(D) are presented. Percentage of annexin-V positive/propidium iodide neg
of anti-CD3/IL2 stimulated PBMCs from a donor after 65 h of treatment at 3
are presented for comparison (G) as are positive controls using the anti-F
the R5 envelope 92MW959 gp120 (I). Percentage of TUNEL positive T cells
plot, and percentage of CD8-bright, TUNEL positive cells are presented in the top
independent experiments utilizing different donor PBMCs for both annexin-V andthe enhanced activity of 92Ug21-9 gp120 in the presence
of sCD4 resulted from the direct interaction of 92Ug21-9
gp120 with CXCR4.
Envelope–coreceptor interactions enhance
gp120-mediated apoptosis
We next asked whether envelope signaling through
CCR5 enhances envelope-mediated apoptosis. To ad-
dress this possibility, we compared the capacity of R5
and X4 envelopes to induce apoptosis in CD41/CCR51 T
cells. Freshly isolated CD41/CCR51 T cells constitute a
relatively small fraction of freshly isolated PBMCs, rang-
ing from 3 to 7% of the total T-lymphocyte population
(data not shown). All of these cells express CXCR4.
PBMCs from five individuals were treated with an R5 or
an X4 envelope and then analyzed for TUNEL positivity
after 65 h. Using mAb markers to identify the CCR51
subset of T lymphocytes, we observed that the R5-spe-
cific envelope induced a higher level of apoptosis in this
subpopulation than the X4 envelope in four of the five
donors tested (Fig. 4). Donor 1 failed to respond to either
envelope. These results suggest that CCR5 signaling
contributes to envelope-mediated apoptosis.
DISCUSSION
In the present study we have addressed the role of
CD4, CXCR4, and CCR5 in envelope-mediated apoptosis
of PBMCs. We compared the capacity of X4 and R5
envelopes to induce apoptosis in activated PBMC cul-
tures. To determine whether CD4–envelope interactions,
in the absence of coreceptor engagement, contribute to
apoptosis, we treated PBMCs from an individual ho-
mozygous for a 32-bp deletion in CCR5 (CCR5D32 null)
with an R5-specific envelope. R5 envelopes were capa-
ble of inducing apoptosis in these cells, indicating that
coreceptor interactions are not an absolute requirement
for envelope-induced apoptosis. In contrast, complexes
of the R5 envelope and sCD4 failed to induce apoptosis
in these PBMCs. These observations are consistent with
reports of anti-CD4 mAb-induced apoptosis of CD41 T
cells (Berndt et al., 1998; Finkel et al., 1995). Of note this
result suggests that the capacity of an envelope to in-
duce apoptosis is not restricted by the expression of a
particular coreceptor. Thus, envelopes, via their ability to
o donors. (A–E) Annexin-V and propidium iodide staining of anti-CD3/IL2
analysis is presented (A). Untreated PBMCs are presented for comparison
X4 envelope 92UG21-9 gp120 (C), and the R5 envelope 92MW959 gp120
lls appear in the lower right quadrant of each plot. (F–J) TUNEL staining
ht scatter of cells included for analysis is presented (F). Untreated PBMCs
CH11 (J). Treatment with the X4 envelope 92UG21-9 gp120 (H), and with
ing the CD8-bright cells, are presented in the lower right quadrant of eache in tw
ded for
ith the
ative ce
7°C. Lig
AS mAb
, excludright quadrant. These results are representative of data obtained from six
TUNEL assays.
itive ce
is.
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sis in microenvironments where the corresponding co-
receptor required for viral entry and replication is absent.
Our analysis demonstrated that the X4 envelope in-
duced higher levels of apoptosis. To assess the role of
CXCR4 in the apoptotic response of T lymphocytes to an
X4 envelope, we prepared complexes of an X4-specific
FIG. 2. Flow cytometric analysis of R5 envelope induced apoptos
anti-CD3/IL2 were treated with envelope protein at 37°C for 65 h an
lymphocytes from two donors, untreated (A and D), treated with the R
Histograms are gated on CD31 T cells. Percentage of TUNEL pos
demonstrates that sCD4 abrogated JR-FL envelope-mediated apoptosenvelope and sCD4. Such complexes should interact
directly with CXCR4 but not with cell surface-bound CD4.Of note, gp120–sCD4 complexes induced higher levels
of apoptosis in T lymphocytes than gp120 alone. This
result demonstrates directly that envelope interactions
with CXCR4 induces apoptosis and is consistent with
previous studies (Berndt et al., 1998; Biard-Piechaczyk et
al., 2000).
The enhancement of X4 envelope-induced apoptosis
CR5D32 homozygous T lymphocytes. T lymphocytes activated with
ed for TUNEL reactivity. The figure shows CCR5D32 homozygous T
lope JR-FL gp120 (B and E), or the R5 envelope 92MW959 gp120 (C).
lls is presented above the boundary marker of each histogram. Fis in C
d stain
5 enveby sCD4 involves the induction of conformational
changes in the envelope that allow optimal interaction
ram. Th
103HIV ENVELOPE-MEDIATED APOPTOSISwith CXCR4 (Lapham et al., 1996; Salzwedel et al., 2000).
The in vivo equivalent of this phenomenon likely relates
the relationship between CD4 and CXCR4 on the cell
membrane. Indeed, several reports suggest that CD4 is
FIG. 3. Flow cytometric analysis of apoptosis induction in T lymphoc
activated with anti-CD3/IL2 were treated with envelope protein at 37°C
treated with 92Ug21-9 (B, F) alone, 92Ug21-9 and sCD4 (C, G), or sCD
positive cells is presented above the boundary marker in each histog
experiments utilizing different donor PBMCs.spatially segregated from CXCR4 on the plasma mem-
brane (Lapham, 1996 No. 100; Xiao, 1999 No. 61) and thatCD4 preferentially associates with other chemokine re-
ceptors including CCR5 (Xiao et al., 1999). In this regard,
the extent to which CD4 and CXCR4 are associated with
each other on various T cell subsets may strongly influ-
an X4 envelope in the presence or absence of sCD4. T lymphocytes
h and stained for TUNEL reactivity. The figure shows untreated (A, E),
(D, H). Histograms are gated on CD31 T cells. Percentage of TUNEL
ese results are representative of data obtained from six independentytes by
for 65
4 aloneence the susceptibility of those subsets to envelope-
induced apoptosis.
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play an active role in envelope-induced apoptosis, we
addressed the role of CCR5 in this process. Addressing
this question directly is made difficult by the fact that
virtually all CCR51 T cells also express CXCR4. Thus,
upon comparing the effects of an R5 vs an X4 envelope
on CCR51 T cells, it is difficult to exclude interactions
between the X4 envelope and CXCR4. Nevertheless, we
found that, when whole PBMCs were treated, the subset
of this population that expressed detectable levels of
CCR5 was more susceptible to an R5 envelope than to
an X4 envelope. Although the difference was modest, it is
striking when compared to our previous result that in-
cluded all T cells (Fig. 1), the majority of which do not
express CCR5. In this population the X4 envelope was
consistently more effective in inducing apoptosis.
In previous studies we and others have shown that
signaling through CCR5 enhances viral replication
(Arthos et al., 2000; Kelly et al., 1998; Kinter et al., 1998).
In this article we have demonstrated that envelope–CD4
engagement alone is sufficient to mediate apoptosis. We
have further demonstrated that envelope–CCR5 and en-
velope–CXCR4 interactions can contribute to envelope-
mediated apoptosis of activated PBMCs. For the latter
however this contribution is limited by the degree of
coassociation between CD4 and CXCR4. Thus, although
the coreceptor specificity of a viral envelope may con-
tribute to apoptosis, it is not the sole determinant. These
conclusions underscore the potential for envelopes to
FIG. 4. Comparison of R5 and X4 envelope induced apoptosis in
CCR51 T lymphocytes. Analysis of TUNEL results after treatment with
the R5 envelope 92MW959 gp120 and the X4 envelope 92Ug21-9 gp120
induced apoptosis from five donor PBMCs. T lymphocytes activated
with anti-CD3/IL2 were treated with envelope protein at 37°C for 65 h
and stained for TUNEL reactivity. Analysis was carried out on the
CCR51 lymphocyte-positive gate. Data represents the percentage in-
crease in TUNEL reactivity in the CCR51 subpopulation of T lympho-
cytes relative to untreated cells of the same phenotype.induce cytopathic effects independent of their coreceptor
specificity.MATERIALS AND METHODS
Cells and reagents
For TUNEL and annexin-V staining, PBMCs were
freshly isolated from individuals by Ficoll–Hypaque cen-
trifugation. Cells from normal donors were determined to
be homozygous for the wild-type CCR5 allele by PCR as
previously described (Liu et al., 1996). Freshly isolated
cells were cultured in RPMI/10% FBS and activated with
anti-CD3 (OKT3) (1 mg/ml) and IL-2 (100 u/ml) for 3 days
prior to envelope or antibody treatment. The antibodies
used for flow cytometry stainings, anti-CCR5, anti-
CXCR4, anti-CD4, anti-CD8, were purchased from
Pharmingen (San Diego, CA). We constructed, ex-
pressed, and purified all envelope proteins in Chinese
hamster ovary (CHO) in an identical manner as previ-
ously described (Arthos et al., 2000; Mossman et al.,
1996; Trkola et al., 1996; Weissman et al., 1997). Envelope
proteins were determined to be endotoxin-free using the
chromogenic limulus amebocyte lysate method (BioWhit-
taker, Walkersville, MD). CHO cell lines expressing these
recombinant envelopes have been provided to the AIDS
Reference and Reagent Program (www.aidsreagent.org).
Envelopes utilized included those derived from HIV-1
JRFL, a CCR5-utilizing molecular clone (O’Brien et al.,
1990); HIV-1 NL43, a tissue culture adapted CXCR4-uti-
lizing molecular clone (Adachi et al., 1986); HIV-1
92Ug21-9, a primary CXCR4-utilizing biological clone
(Gao et al., 1994); and HIV-1 92MW959, a CCR5-utilizing
biological clone (Gao et al., 1994). Coreceptor utilization
is described in “Coreceptor Use by Primate Lentiviruses”
url: hiv-web.lanl.gov/REVIEWS/BRODER99/coreceptor.
html. In addition 92Ug21-9 is a CXCRX4-specific enve-
lope as described in Genbank submission, Accession
No. U08804. Soluble CD4 (sCD4) (SmithKline Beecham,
King of Prussia, PA) was used to generate envelope/
sCD4 complexes. The anti-Fas mAb CH11 (Beckman-
Coulter, Fullerton, CA) was used as a positive control for
both annexin-V and TUNEL assays. Reference controls
designated as untreated included an appropriate volume
of a mock protein preparation derived and purified from
the parental CHO cell line from which each of the gp120-
expressing cell lines was derived.
Annexin V staining
Freshly isolated PBMCs (2 3 105 cells) were cultured
in RPMI/10% FBS in 96-well plates. Cells were treated
with HIV envelope (50 nM) for 5 h at 37°C and subse-
quently stained with annexin-V FITC and propidium io-
dide per manufacturers’ instructions (R & D Technolo-
gies, Minneapolis, MN). The FAS mAb CH11 was used as
a positive control to induce apoptosis. Untreated controls
included a mock protein preparation. FAS-treated cells
were used to define the population (by light scatter) of
lymphocytes analyzed. We defined quadrants based
105HIV ENVELOPE-MEDIATED APOPTOSISupon the annexin-V staining of the untreated population
(negative control) such that greater than 97% of the cells
fall within the lower left quadrant. For each donor we
compared the light scatter of untreated cells vs cells
treated with the anti-FAS mAb CH11. Upon treatment with
CH11, a distinct population of cells appears. We draw our
gate to include that population.
TUNEL assays
Freshly isolated PBMCs (2 3 105 cells) were cultured
in RPMI/10% FBS in 96-well plates. Cells were treated
with envelope (50–100 nM) for approximately 65 h at
37°C and with terminal deoxynucleotidyl transferase ac-
cording to the manufacturer’s instructions (Beckman-
Coulter, Miami, FL). A lymphocyte gate was established
using forward and side light scatter. For each donor we
compared the light scatter of untreated cells vs cells
treated with the anti-FAS mAb CH11. Upon treatment with
CH11, a distinct population of cells appears. We draw our
gate to include that population. Cells were stained with
anti-CD3, anti-CD8, and FITC-labeled dUTP. The FAS
mAb CH11 was used a positive control to induce apop-
tosis. Mock protein preparations were included in the
untreated control.
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